Replimune Group (REPL) PT Lowered to $6 at Jefferies, Buy rating kept, 'see the reasonable case as accelerated approval based on interim results'
Tweet Send to a Friend
(Updated - July 22, 2025 11:18 AM EDT)
Jefferies analyst Roger Song lowered the price target on Replimune Group ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Roger Song lowered the price target on Replimune Group ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
